Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ventilatory Modes01:14

Ventilatory Modes

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Backrest Position and Outcome in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Protocol for a Multi-Center Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial.

Acta anaesthesiologica Scandinavica·2026
Same author

Prophylactic Olanzapine Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial.

Acta anaesthesiologica Scandinavica·2026
Same author

The Danish Out-of-Hospital Cardiac Arrest Trial: A Statistical Analysis Plan.

Acta anaesthesiologica Scandinavica·2026
Same author

Dexamethasone Versus Placebo in Comatose Survivors of Out-of-Hospital Cardiac Arrest: Study Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest Trial (DANOHCA).

Acta anaesthesiologica Scandinavica·2026
Same author

Help-seeking and barriers to emergency care during out-of-hospital cardiac arrests in public housing areas: a qualitative study.

BMJ open·2026
Same author

Early Versus Late Wake-Up Call After Out-Of-Hospital Cardiac Arrest: Protocol for a Multicenter Randomized Comparison Within the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) Trial.

Acta anaesthesiologica Scandinavica·2026

Related Experiment Video

Updated: Jun 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Mechanical circulatory support: when, how, and for whom.

Jacob Eifer Møller1,2, Holger Thiele3, David Morrow4

  • 1Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen DK-2100, Denmark.

European Heart Journal
|January 10, 2025
PubMed
Summary
This summary is machine-generated.

Temporary mechanical circulatory support can stabilize patients with cardiogenic shock. Optimal use, patient selection, and timing for these devices require further research, especially in non-ischaemic cases.

Keywords:
Acute myocardial infarctionCardiogenic shockClinical trialsMechanical circulatory support

More Related Videos

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Biomedical Engineering

Background:

  • Cardiogenic shock is a life-threatening condition where the heart fails to pump enough blood, leading to organ damage.
  • Temporary mechanical circulatory support (MCS) devices offer a potential solution for hemodynamic stabilization.
  • Current guidelines for MCS use in cardiogenic shock are often based on limited evidence, particularly in non-ischaemic etiologies.

Purpose of the Study:

  • To review the optimal timing, patient selection, and implementation strategies for temporary mechanical circulatory support in cardiogenic shock.
  • To examine the clinical scenarios and mechanisms of action for various temporary MCS devices.
  • To identify evidence gaps and areas for future research in the application of temporary MCS.

Main Methods:

  • Systematic review of existing literature on temporary mechanical circulatory support in cardiogenic shock.
  • Analysis of clinical data and expert consensus regarding device use.
  • Exploration of device mechanisms and patient-specific benefits.

Main Results:

  • Temporary MCS can serve as a bridge to recovery, decision-making, or definitive therapy.
  • Optimal use is complex and often relies on observational data and expert opinion, especially in non-ischaemic shock.
  • Significant gaps in evidence exist regarding the precise 'when, how, and for whom' of temporary MCS deployment.

Conclusions:

  • Temporary mechanical circulatory support is a vital tool in managing cardiogenic shock.
  • Further research, including randomized controlled trials, is needed to refine patient selection, timing, and implementation protocols.
  • A deeper understanding of the human-device interaction is crucial for optimizing outcomes in temporary MCS therapy.